Document Detail


Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair.
MedLine Citation:
PMID:  21098445     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: Cardiac cell therapy for older patients who experience a myocardial infarction may require highly regenerative cells from young, healthy (allogeneic) donors. Bone marrow mesenchymal stem cells (MSCs) are currently under clinical investigation because they can induce cardiac repair and may also be immunoprivileged (suitable for allogeneic applications). However, it is unclear whether allogeneic MSCs retain their immunoprivilege or functional efficacy late after myocardial implantation. We evaluated the effects of MSC differentiation on the immune characteristics of cells in vitro and in vivo and monitored cardiac function for 6 months after post-myocardial infarction MSC therapy.
METHODS AND RESULTS: In the in vitro experiments, inducing MSCs to acquire myogenic, endothelial, or smooth muscle characteristics (via 5-azacytidine or cytokine treatment) increased major histocompatibility complex-Ia and -II (immunogenic) expression and reduced major histocompatibility complex-Ib (immunosuppressive) expression, in association with increased cytotoxicity in coculture with allogeneic leukocytes. In the in vivo experiments, we implanted allogeneic or syngeneic MSCs into infarcted rat myocardia. We measured cell differentiation and survival (immunohistochemistry, real-time polymerase chain reaction) and cardiac function (echocardiography, pressure-volume catheter) for 6 months. MSCs (versus media) significantly improved ventricular function for at least 3 months after implantation. Allogeneic (but not syngeneic) cells were eliminated from the heart by 5 weeks after implantation, and their functional benefits were lost within 5 months.
CONCLUSIONS: The long-term ability of allogeneic MSCs to preserve function in the infarcted heart is limited by a biphasic immune response whereby they transition from an immunoprivileged to an immunogenic state after differentiation, which is associated with an alteration in major histocompatibility complex-immune antigen profile.
Authors:
Xi-Ping Huang; Zhuo Sun; Yasuo Miyagi; Heather McDonald Kinkaid; Li Zhang; Richard D Weisel; Ren-Ke Li
Related Documents :
9066475 - First myocardial infarction in patients of indian subcontinent and european origin: com...
3108555 - The mikamo lecture. tomographic assessment of myocardial perfusion and metabolism in th...
20598975 - Left ventricular function in acute myocardial infarction treated with thrombolysis foll...
10158385 - Overview of intracoronary thrombolysis.
3978705 - Successful result from delayed streptokinase administration: subtotal thrombotic occlus...
1742905 - Influence of minimal angiographic visible collateral circulation on myocardial function...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-11-22
Journal Detail:
Title:  Circulation     Volume:  122     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-12-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2419-29     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, Division of Cardiovascular Surgery, University of Toronto and University Health Network, Toronto, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Grant Support
ID/Acronym/Agency:
MOP102535//Canadian Institutes of Health Research; MOP14795//Canadian Institutes of Health Research; RMF82498//Canadian Institutes of Health Research

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970...
Next Document:  MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation.